1.Current progress in antimicrobial peptides against bacterial biofilms.
Wenbo WANG ; Guannan WANG ; Shasha CAI
Chinese Journal of Biotechnology 2020;36(7):1277-1282
Microbial biofilm, a consortium of microbial cells protected by a self-produced polymer matrix, is considered as one main cause of current bacterial drug resistance. As a new type of antimicrobial agents, antimicrobial peptides provide a new strategy for the treatment of antibiotic resistant bacteria biofilm infections. Antimicrobial peptides have shown unique advantages in preventing microbial colonization of surfaces, killing bacteria in biofilms or disrupting the mature biofilm structure. This review systemically analyzes published data in the recent 30 years to summarize the possible anti-biofilm mechanisms of antimicrobial peptides. We hope that this review can provide reference for the treatment of infectious diseases by pathogenic microbial biofilm.
Anti-Bacterial Agents
;
pharmacology
;
Antimicrobial Cationic Peptides
;
pharmacology
;
Bacteria
;
drug effects
;
Biofilms
;
drug effects
;
Drug Resistance, Bacterial
;
drug effects
;
Microbial Sensitivity Tests
;
Research
;
trends
2.Drug utilization review of mupirocin ointment in a Korean university-affiliated hospital.
Sung Hee YOUN ; Seung Soon LEE ; Sukyeon KIM ; Jeong A LEE ; Bum Joon KIM ; Jounghee KIM ; Hye Kyung HAN ; Jae Seok KIM
The Korean Journal of Internal Medicine 2015;30(4):515-520
BACKGROUND/AIMS: Intranasal mupirocin and chlorhexidine bathing are candidate strategies to prevent healthcare-associated infections caused by methicillin-resistant Staphylococcus aureus (MRSA). In Korea, intranasal mupirocin is not available, and mupirocin ointment, an over-the-counter drug, has been used indiscriminately. Furthermore, because it is covered by health insurance, mupirocin is easy to prescribe within hospitals. METHODS: We performed a mupirocin drug utilization review (DUR) within Hallym University Sacred Heart Hospital. Annual use of mupirocin was investigated between 2003 and 2013, and monthly consumption of mupirocin was assessed during the final 2-year period. The DUR focused on August 2012, the period of highest use of mupirocin. Also, we investigated trends in mupirocin resistance in MRSA between 2011 and 2013. RESULTS: Annual consumption of mupirocin increased from 3,529 tubes in 2003 to 6,475 tubes in 2013. During August 2012, 817 tubes were prescribed to 598 patients; of these, 84.9% were prescribed to outpatients, and 77.6% at the dermatology department. The most common indication was prevention of skin infections (84.9%), and the ointment was combined with systemic antibiotics in 62.9% of cases. The average duration of systemic antibiotic administration was about 7.8 days. The rate of low-level mupirocin resistance in MRSA increased from 8.0% to 22.0%, and that of high-level mupirocin resistance increased from about 4.0% to about 7.5%. CONCLUSIONS: Inappropriate use of mupirocin is prevalent. Considering the increase in resistance and the future application of intranasal mupirocin, prophylactic use of mupirocin in dermatology departments should be reconsidered.
Administration, Cutaneous
;
Anti-Bacterial Agents/*administration & dosage/adverse effects
;
Drug Prescriptions
;
Drug Resistance, Multiple, Bacterial
;
Drug Utilization Review
;
*Hospitals, University
;
Humans
;
Inappropriate Prescribing/*trends
;
Methicillin-Resistant Staphylococcus aureus/*drug effects
;
Microbial Sensitivity Tests
;
Mupirocin/*administration & dosage/adverse effects
;
Ointments
;
Practice Patterns, Physicians'/*trends
;
Predictive Value of Tests
;
Republic of Korea
;
Retrospective Studies
;
Staphylococcal Skin Infections/diagnosis/*drug therapy/microbiology
;
Time Factors
3.Increasing Carbapenem-Resistant Gram-Negative Bacilli and Decreasing Metallo-beta-Lactamase Producers over Eight Years from Korea.
Yangsoon LEE ; Chang Ki KIM ; Hae Sun CHUNG ; Dongeun YONG ; Seok Hoon JEONG ; Kyungwon LEE ; Yunsop CHONG
Yonsei Medical Journal 2015;56(2):572-577
The trends and types of carbapenemase-producing Gram-negative bacilli were analyzed from clinical specimens collected between 2005 and 2012 at a Korean teaching hospital. The proportions of carbapenem-resistant Acinetobacter spp. increased markedly to 66%. Metallo-beta-lactamase producers significantly decreased and the majority shifted from the bla(VIM-2) type to the bla(IMP-1) type.
Acinetobacter/classification/drug effects/*enzymology
;
Acinetobacter Infections/drug therapy
;
Anti-Bacterial Agents/*pharmacology
;
Bacterial Proteins
;
Carbapenems/*pharmacology
;
Drug Resistance, Microbial
;
Gram-Negative Bacteria/*drug effects/enzymology/isolation & purification
;
Humans
;
Incidence
;
Microbial Sensitivity Tests/trends
;
Population Surveillance
;
Pseudomonas/classification/drug effects/enzymology
;
Republic of Korea/epidemiology
;
beta-Lactamases/biosynthesis/*drug effects